- Report
- July 2024
- 200 Pages
Global
From €4406EUR$4,949USD£3,808GBP
- Report
- May 2023
- 160 Pages
Global
From €4406EUR$4,949USD£3,808GBP
- Report
- December 2024
- 36 Pages
Canada
From €312EUR$350USD£269GBP
- Report
- May 2025
- 44 Pages
Canada
From €828EUR$930USD£716GBP
- Report
- May 2025
- 148 Pages
India
From €2226EUR$2,500USD£1,924GBP
- Report
- September 2024
- 119 Pages
Saudi Arabia
From €1603EUR$1,800USD£1,385GBP
- Training
- 60 Minutes
Global
- Report
- March 2025
- 56 Pages
China
From €1603EUR$1,800USD£1,385GBP
- Report
- March 2025
- 220 Pages
China
From €3561EUR$4,000USD£3,078GBP
The Generic Drug Production market is a segment of the pharmaceutical industry that focuses on the production of generic drugs. Generic drugs are copies of brand-name drugs that have the same active ingredients, dosage form, strength, route of administration, safety, efficacy, and intended use. Generic drugs are typically much less expensive than their brand-name counterparts, making them a more affordable option for many patients.
Generic drug production involves the manufacture of active pharmaceutical ingredients (APIs) and the formulation of finished dosage forms. APIs are the active ingredients in a drug that are responsible for its therapeutic effects. The production of APIs requires the use of sophisticated manufacturing processes and quality control measures to ensure that the drug is safe and effective. The formulation of finished dosage forms involves the blending of APIs with other inactive ingredients to create a drug product that is ready for use.
Generic drug production is a highly regulated industry, with stringent quality control measures in place to ensure the safety and efficacy of the drugs. Companies in the Generic Drug Production market include Teva Pharmaceuticals, Mylan, Sandoz, and Dr. Reddy's Laboratories. Show Less Read more